Study finds rapamycin may prolong women's fertility by 5 years and slow ovarian aging.
A study suggests that rapamycin, an immunosuppressant drug, could potentially prolong women's fertility by five years. Early results indicate that the drug is safe for young, healthy women and that it may decrease ovary ageing by 20%. The Validating Benefits of Rapamycin for Reproductive Aging Treatment (Vibrant) study aims to measure whether the drug can slow ovaries ageing, thereby delaying menopause, extending fertility, and reducing the risk of age-related diseases.
July 22, 2024
5 Articles